Search Results - "Maina, E.K"

Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya by Maina, E.K., Mureithi, H., Adan, A.A., Muriuki, J., Lwembe, R.M., Bukusi, E.A.

“…•The rate of viral suppression in patients on cART remains below the UNAIDS target of 90% by 2020.•Durable viral suppression noted in this study is a sign that…”
Get full text

Superantigenic activity of toxic shock syndrome toxin-1 is resistant to heating and digestive enzymes by Li, S.-J, Hu, D.-L, Maina, E.K, Shinagawa, K, Omoe, K, Nakane, A

“…Aims: To elucidate the stability of superantigenic activity and pathogenesis of toxic shock syndrome toxin 1 (TSST-1) and staphylococcal enterotoxin A (SEA)…”
Get full text

CD4+ T cell counts in initiation of antiretroviral therapy in HIV infected asymptomatic individuals; controversies and inconsistencies by Maina, E.K, Bonney, E.Y, Bukusi, E.A, Sedegah, M, Lartey, M, Ampofo, W.K

“…Highlights • Assesses available data on optimal time to initiate therapy in HIV-infected asymptomatic individuals with respect to CD4+ T cell threshold. •…”
Get full text

Superantigenic activity of toxic shock syndrome toxin-1 is resistant to heating and digestive enzymes: Stability of TSST-1 to heat and enzymes by Li, S.-J., Hu, D.-L., Maina, E.K., Shinagawa, K., Omoe, K., Nakane, A.

Get full text

Superantigenic activity of toxic shock syndrome toxin-1 is resistant to heating and digestive enzymes: Stability of TSST-1 to heat and enzymes by Li, S.-J., Hu, D.-L., Maina, E.K., Shinagawa, K., Omoe, K., Nakane, A.

Get full text